| Protein processing in endoplasmic reticulum |
2.76 |
0.00e+0 |
127/171 (74.27%) |
HSPA1A;HERPUD1;HSPA6;...
|
| Legionellosis |
2.59 |
0.00e+0 |
51/57 (89.47%) |
HSPA1A;HSPA6;HSPA8;...
|
| TNF signaling pathway |
2.30 |
0.00e+0 |
103/112 (91.96%) |
ATF4;TNFAIP3;CEBPB;...
|
| Longevity regulating pathway |
2.28 |
0.00e+0 |
90/151 (59.6%) |
HSPA1A;HSPA6;HSPA8;...
|
| Lipid and atherosclerosis |
2.24 |
0.00e+0 |
190/215 (88.37%) |
HSPA1A;HSPA6;DDIT3;...
|
| Antigen processing and presentation |
2.22 |
0.00e+0 |
60/78 (76.92%) |
HSPA1A;HSPA6;HSPA8;...
|
| Measles |
2.20 |
0.00e+0 |
133/139 (95.68%) |
HSPA1A;HSPA6;HSPA8;...
|
| Ferroptosis |
2.11 |
0.00e+0 |
36/41 (87.8%) |
HMOX1;SLC7A11;SLC3A2;...
|
| NF-kappa B signaling pathway |
2.03 |
0.00e+0 |
90/104 (86.54%) |
CXCL8;RELB;TNFAIP3;...
|
| Prostate cancer |
2.03 |
0.00e+0 |
93/97 (95.88%) |
ATF4;HSP90AA1;CDKN1A;...
|
| Mitophagy |
2.00 |
0.00e+0 |
56/68 (82.35%) |
ATF4;EIF2AK3;SQSTM1;...
|
| IL-17 signaling pathway |
1.96 |
0.00e+0 |
84/94 (89.36%) |
CXCL8;TNFAIP3;HSP90AA1;...
|
| Osteoclast differentiation |
1.94 |
0.00e+0 |
117/127 (92.13%) |
RELB;SQSTM1;JUN;...
|
| Epstein-Barr virus infection |
1.94 |
7.62e-4 |
189/202 (93.56%) |
RELB;TNFAIP3;GADD45A;...
|
| Toxoplasmosis |
1.93 |
7.12e-4 |
103/112 (91.96%) |
HSPA1A;HSPA6;HSPA8;...
|
| Estrogen signaling pathway |
1.92 |
2.67e-3 |
119/137 (86.86%) |
HSPA1A;HSPA6;HSPA8;...
|
| Herpes simplex virus 1 infection |
1.90 |
2.51e-3 |
165/498 (33.13%) |
EIF2AK3;HLA-DQA1;BIRC2;...
|
| Autophagy |
1.89 |
3.56e-3 |
113/169 (66.86%) |
DDIT4;EIF2AK3;IRS2;...
|
| Kaposi sarcoma-associated herpesvirus infection |
1.82 |
8.99e-3 |
172/193 (89.12%) |
CXCL8;CDKN1A;VEGFA;...
|
| Rheumatoid arthritis |
1.81 |
9.07e-3 |
78/93 (83.87%) |
CXCL8;VEGFA;HLA-DQA1;...
|
| Apoptosis |
1.80 |
9.15e-3 |
126/168 (75%) |
DDIT3;ATF4;PMAIP1;...
|
| mRNA surveillance pathway |
1.79 |
9.70e-3 |
71/98 (72.45%) |
NXF1;RNMT;PAPOLA;...
|
| Spliceosome |
1.79 |
9.75e-3 |
101/150 (67.33%) |
HSPA1A;HSPA6;HSPA8;...
|
| Epithelial cell signaling in Helicobacter pylori infect... |
1.77 |
1.16e-2 |
62/70 (88.57%) |
CXCL8;JUN;NFKBIA;...
|
| NOD-like receptor signaling pathway |
1.74 |
1.45e-2 |
145/181 (80.11%) |
CXCL8;TNFAIP3;HSP90AA1;...
|
| Cocaine addiction |
1.73 |
1.72e-2 |
42/49 (85.71%) |
ATF4;JUN;CREB3L2;...
|
| Protein export |
1.72 |
1.78e-2 |
17/23 (73.91%) |
HSPA5;SRPRA;SEC63;...
|
| Tuberculosis |
1.71 |
2.06e-2 |
159/180 (88.33%) |
CEBPG;HSPD1;HLA-DQA1;...
|
| Hepatitis C |
1.68 |
2.76e-2 |
139/157 (88.54%) |
EIF2AK3;CDKN1A;NFKBIA;...
|
| MAPK signaling pathway |
1.67 |
2.92e-2 |
272/294 (92.52%) |
HSPA1A;HSPA6;DDIT3;...
|
| Galactose metabolism |
-1.59 |
4.75e-2 |
26/31 (83.87%) |
SI;GAA;GALE;...
|
| Tyrosine metabolism |
-1.59 |
4.83e-2 |
30/36 (83.33%) |
ALDH3A1;MIF;FAH;...
|
| Fat digestion and absorption |
-1.65 |
2.70e-2 |
35/43 (81.4%) |
GOT2;ACAT2;DGAT1;...
|
| Thermogenesis |
-1.66 |
2.53e-2 |
173/232 (74.57%) |
CYC1;ADRB3;COX6B1;...
|
| Oocyte meiosis |
-1.67 |
2.52e-2 |
90/129 (69.77%) |
PRKACB;CCNE1;PPP2R5C;...
|
| Purine metabolism |
-1.67 |
2.55e-2 |
102/129 (79.07%) |
PGM1;CANT1;PAPSS1;...
|
| Vitamin digestion and absorption |
-1.68 |
2.59e-2 |
17/24 (70.83%) |
APOA4;BTD;SCARB1;...
|
| ECM-receptor interaction |
-1.68 |
2.58e-2 |
80/88 (90.91%) |
ITGB7;COL4A1;COL4A5;...
|
| Morphine addiction |
-1.68 |
2.62e-2 |
80/91 (87.91%) |
GNAI2;GRK3;GNB3;...
|
| Regulation of lipolysis in adipocytes |
-1.69 |
2.67e-2 |
52/55 (94.55%) |
AKT1;ADRB2;LIPE;...
|
| Nucleotide excision repair |
-1.70 |
2.41e-2 |
40/47 (85.11%) |
CETN2;POLD3;POLD4;...
|
| Mannose type O-glycan biosynthesis |
-1.70 |
2.45e-2 |
14/23 (60.87%) |
RXYLT1;POMT1;B4GALT3;...
|
| Pyrimidine metabolism |
-1.72 |
2.21e-2 |
40/56 (71.43%) |
CTPS2;TK2;CANT1;...
|
| Citrate cycle (TCA cycle) |
-1.73 |
1.93e-2 |
30/30 (100%) |
SDHA;ACLY;OGDH;...
|
| Valine, leucine and isoleucine degradation |
-1.73 |
1.94e-2 |
42/48 (87.5%) |
ACAD8;ALDH9A1;ACADS;...
|
| Mismatch repair |
-1.74 |
1.86e-2 |
22/23 (95.65%) |
RPA2;RFC4;MSH6;...
|
| Glycolysis / Gluconeogenesis |
-1.75 |
2.06e-2 |
56/67 (83.58%) |
DLD;ALDOA;GAPDH;...
|
| Base excision repair |
-1.87 |
5.80e-3 |
29/33 (87.88%) |
LIG3;APEX2;NTHL1;...
|
| Glutathione metabolism |
-1.91 |
3.98e-3 |
43/57 (75.44%) |
RRM1;GPX1;GSTM1;...
|
| Metabolism of xenobiotics by cytochrome P450 |
-1.92 |
3.09e-3 |
49/77 (63.64%) |
CYP2C9;CBR1;GSTM1;...
|
| Pentose phosphate pathway |
-1.98 |
1.86e-3 |
25/30 (83.33%) |
G6PD;PGM1;PGLS;...
|
| Drug metabolism |
-2.00 |
2.32e-3 |
78/151 (51.66%) |
MAOB;CYP2C9;TPMT;...
|
| Retrograde endocannabinoid signaling |
-2.02 |
3.09e-3 |
118/148 (79.73%) |
NDUFS8;GNAI2;GNB3;...
|
| Fatty acid degradation |
-2.04 |
4.64e-3 |
40/43 (93.02%) |
ALDH9A1;ACADS;ACAA1;...
|
| DNA replication |
-2.15 |
0.00e+0 |
34/36 (94.44%) |
RPA2;RNASEH2B;RFC4;...
|
